| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-Chain (CD3)1
,
* Department of Pathology, Louisiana State University Health Sciences Center, New Orleans, LA 70112;
Department of Microbiology and Immunology, University of South Alabama, Mobile, AL 36688;
Department of Pediatrics, Louisiana State University Health Science Center, and
Tumor Immunology Laboratory, Stanley S. Scott Cancer Center, New Orleans, LA 70112
Helicobacter pylori infects approximately half the human population. The outcomes of the infection range from gastritis to gastric cancer and appear to be associated with the immunity to H. pylori. Patients developing nonatrophic gastritis present a Th1 response without developing protective immunity, suggesting that this bacterium may have mechanisms to evade the immune response of the host. Several H. pylori proteins can impair macrophage and T cell function in vitro through mechanisms that are poorly understood. We tested the effect of H. pylori extracts and live H. pylori on Jurkat cells and freshly isolated human normal T lymphocytes to identify possible mechanisms by which the bacteria might impair T cell function. Jurkat cells or activated T lymphocytes cultured with an H. pylori sonicate had a reduced proliferation that was not caused by T cell apoptosis or impairment in the early T cell signaling events. Instead, both the H. pylori sonicate and live H. pylori induced a decreased expression of the CD3
-chain of the TCR. Coculture of live H. pylori with T cells demonstrated that the wild-type strain, but not the arginase mutant rocF(–), depleted L-arginine and caused a decrease in CD3 expression. Furthermore, arginase inhibitors reversed these events. These results suggest that H. pylori arginase is not only important for urea production, but may also impair T cell function during infection.
This article has been cited by other articles:
|
|
 |
|
  P. C. Rodriguez, D. G. Quiceno, and A. C. Ochoa L-arginine availability regulates T-lymphocyte cell-cycle progression Blood, February 15, 2007; 109(4): 1568 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yang, D. Rangasamy, K. I. Matthaei, A. J. Frew, N. Zimmmermann, S. Mahalingam, D. C. Webb, D. J. Tremethick, P. J. Thompson, S. P. Hogan, et al. Inhibition of Arginase I Activity by RNA Interference Attenuates IL-13-Induced Airways Hyperresponsiveness J. Immunol., October 15, 2006; 177(8): 5595 - 5603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. S. Algood and T. L. Cover Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses Clin. Microbiol. Rev., October 1, 2006; 19(4): 597 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. McGee, S. Kumar, R. J. Viator, J. R. Bolland, J. Ruiz, D. Spadafora, T. L. Testerman, D. J. Kelly, L. K. Pannell, and H. J. Windle Helicobacter pylori Thioredoxin Is an Arginase Chaperone and Guardian against Oxidative and Nitrosative Stresses J. Biol. Chem., February 10, 2006; 281(6): 3290 - 3296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sinha, V. K. Clements, and S. Ostrand-Rosenberg Interleukin-13-regulated M2 Macrophages in Combination with Myeloid Suppressor Cells Block Immune Surveillance against Metastasis Cancer Res., December 15, 2005; 65(24): 11743 - 11751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pinto-Santini and N. R. Salama The Biology of Helicobacter pylori Infection, a Major Risk Factor for Gastric Adenocarcinoma Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1853 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kranzer, L. Sollner, M. Aigner, N. Lehn, L. Deml, M. Rehli, and W. Schneider-Brachert Impact of Helicobacter pylori Virulence Factors and Compounds on Activation and Maturation of Human Dendritic Cells Infect. Immun., July 1, 2005; 73(7): 4180 - 4189. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
